Infantile Bullous Pemphigoid: Vaccination and SARS-CoV-2 Infection as Triggers.

Moens, Héloïse;Delcambre, Louise;De Greef, Axel;Leboutte, Marie-Emeline;Baeck, Marie
(2024) Cureus — Vol. 16, n° 8, p. e66303 [1-5] (2024)

Files

cureus-0016-00000066303.pdf
  • Open Access
  • Adobe PDF
  • 3.25 MB
Download

Details

Authors
  • Moens, HéloïseUCLouvain
    Author
  • Delcambre, LouiseUCLouvain
    Author
  • De Greef, Axelorcid-logoUCLouvain
    Author
  • Leboutte, Marie-Emeline
    Author
  • Baeck, MarieUCLouvain
    Author
Abstract
Bullous pemphigoid (BP) is an acquired auto-immune blistering disease, which is uncommon during childhood. Infantile BP usually has a good prognosis with rare recurrence and the suspected triggers are vaccines or viruses. We report the case of a three-month-old infant girl who presented with BP a week after a SARS-CoV-2 infection and three weeks after the first doses of polio, tetanus, diphtheria, pertussis, Haemophilus influenzae type-b, hepatitis, and pneumococcus vaccinations. Both triggers (infection and vaccination) could be implicated as a slight recurrence was observed after the second doses of vaccines. Rapid clinical resolution was obtained with topical corticosteroids.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Moens, H., Delcambre, L., De Greef, A., Leboutte, M.-E., & Baeck, M. (2024). Infantile Bullous Pemphigoid: Vaccination and SARS-CoV-2 Infection as Triggers. Cureus, 16(8), e66303 [1-5]. https://doi.org/10.7759/cureus.66303 (Original work published 2024)